Literature DB >> 21721149

Effects of acupuncture at Taixi acupoint (KI3) on kidney proteome.

Chun-Ri Li1, Ze-Dong Cheng, Zhi-Xing Zhang, Andre Kim, Jong-Myung Ha, Yuan-Yuan Song, Jie Zheng, Yi-Guo Chen.   

Abstract

This research explored and identified the protein composition of rat kidneys after acupuncture at the Taixi acupoint (KI3). Twelve adult male Wistar rats were randomly divided into a control group (n = 6) and an acupuncture group (n = 6). Rats in the acupuncture group received electroacupuncture on the bilateral KI3 for seven days. The kidneys were perfused with ice-cold saline and all kidney proteins were isolated. After protein sample preparation, two-dimensional gel electrophoresis (2-DE) was performed. The interesting spots were analyzed using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). There were nine protein spots with three-fold up-regulation in the kidney after the acupuncture. NAD-dependent isocitrate dehydrogenase and quinone reductase, the proteins involved in energy metabolism, the reduction of endogenous quinones, chemoprotection, and electrophilic stress, were identified. The data indicated that acupuncture at the KI3 of the kidney meridian of the foot shaoyin was able to increase NAD-dependent isocitrate dehydrogenase and quinone reductase expression in the kidney, and supported the relationship between the kidney and KI3.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21721149     DOI: 10.1142/S0192415X11009123

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  2 in total

1.  Characteristics of five-phase acupoints from data mining of randomized controlled clinical trials followed by multidimensional scaling.

Authors:  Seoyoung Lee; Yeonhee Ryu; Hi-Joon Park; In-Seon Lee; Younbyoung Chae
Journal:  Integr Med Res       Date:  2021-12-22

Review 2.  Recent Advance in Applications of Proteomics Technologies on Traditional Chinese Medicine Research.

Authors:  Qing Ji; Fangshi Zhu; Xuan Liu; Qi Li; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.